Application 208717
- Type
- ANDA
- Sponsor
- CADILA PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | No | No |
| 004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208717-001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | |
| A208717-002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | |
| A208717-003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | |
| A208717-004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208717-001 | AB |
| A208717-002 | AB |
| A208717-003 | AB |
| A208717-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2021-12-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2021-12-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2021-12-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2021-12-17 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208717-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208717-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208717-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208717-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208717-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208717-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208717-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208717-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208717-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208717-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208717-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208717-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208717-004 | AB | 1 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nebivolol | NEBIVOLOL | Bryant Ranch Prepack | 0ca84bf1-511d-480d-ba3d-0eef00ddad3e | 2024-10-31 | Warnings, Adverse reactions | 208717 ANDA208717 |
| Nebivolol | NEBIVOLOL | Bryant Ranch Prepack | 04a64dad-6922-4737-ab46-98c185782b38 | 2024-10-31 | Warnings, Adverse reactions | 208717 ANDA208717 |
| Nebivolol | NEBIVOLOL | Bryant Ranch Prepack | abb0546f-08dd-4354-8b41-d17065b52c24 | 2024-10-31 | Warnings, Adverse reactions | 208717 ANDA208717 |
| Nebivolol | NEBIVOLOL | Bryant Ranch Prepack | 9a5e1bd8-f2b6-42e6-972d-09418528cd63 | 2024-10-31 | Warnings, Adverse reactions | 208717 ANDA208717 |
| Nebivolol | NEBIVOLOL | Modavar Pharmaceuticals LLC | 19d20396-ade8-400e-94f4-69913637d051 | 2023-11-09 | Warnings, Adverse reactions | 208717 ANDA208717 72241-035 72241-034 72241-032 72241-033 |
| Nebivolol | NEBIVOLOL | Cadila Pharmaceuticals Limited | 451cdd6e-13b4-402f-8a44-cdf5f7433a49 | 2023-11-01 | Warnings, Adverse reactions | 208717 ANDA208717 71209-061 71209-060 71209-059 71209-058 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 71209-058 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-058 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-059 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-059 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-060 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-060 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-061 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 71209-061 | Nebivolol | Nebivolol | Cadila Pharmaceuticals Limited | ANDA | Current |
| 72241-032 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-032 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-033 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-033 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-034 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-034 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-035 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |
| 72241-035 | Nebivolol | Nebivolol | Modavar Pharmaceuticals LLC | ANDA | Current |